Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles

References

• ZhangHYAdvance in the research of quetiapine fumarate extended-release tablets, a new formulation for atypical antipsychoticsChin J New Drugs20152413538
   Google Scholar
• Quetiapine fumarate Available from: https://www.drugs.com/monograph/quetiapine-fumarate.htmlAccessed June 23, 2018
   Google Scholar
• RiedelMMüllerNStrassnigMSpellmannISeverusEMöllerHJQuetiapine in the treatment of schizophrenia and related disordersNeuropsychiatr Dis Treat20073221923519300555
   PubMedGoogle Scholar
• Yaozh.com [homepage on the Internet]Searching “Quetiapine fumarate” in import drug database Available from: https://db.yaozh.com/jinkou?comprehensivesearchcontent=quetiapine&Accessed June 23, 2018 Chinese
   Google Scholar
• GunasekaraNSSpencerCMQuetiapine: A Review of its Use in SchizophreniaCNS Drugs19989432534027521016
   PubMed Web of Science ®Google Scholar
• HuiKOSulaimanAHGillJSPillaiSKJambunathanSTRashidRAA 3-week, open label study to evaluate the efficacy and safety of extended release quetiapine fumarate in the treatment of agitation in patients with schizophreniaKlinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology20132311423
   Web of Science ®Google Scholar
• NaberDPeuskensJSchwarzmannNSubjective well-being in schizophrenia: a randomised controlled open-label 12-month non-inferiority study comparing quetiapine XR with risperidone (RECOVER)Eur Neuropsychopharmacol201323101257126923953270
   PubMed Web of Science ®Google Scholar
• CristanchoMAThaseMEThe role of quetiapine extended release in the treatment of bipolar depressionAdv Ther2010271177478420835785
   PubMed Web of Science ®Google Scholar
• KetterTAMillerSDell’OssoBWangPWTreatment of bipolar disorder: Review of evidence regarding quetiapine and lithiumJ Affect Disord201619125627326688495
   PubMed Web of Science ®Google Scholar
• GarrigaMSoléEGonzález-PintoAEfficacy of quetiapine XR vs placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trialEur Neuropsychopharmacol2017271095996928882405
   PubMed Web of Science ®Google Scholar
• PaeCUSohiMSSeoHJQuetiapine XR: current status for the treatment of major depressive disorderProg Neuropsychopharmacol Biol Psychiatry20103471165117320307622
   PubMed Web of Science ®Google Scholar
• IgnácioZMCalixtoAVda SilvaRHQuevedoJRéusGZThe use of quetiapine in the treatment of major depressive disorder: Evidence from clinical and experimental studiesNeurosci Biobehav Rev201886365029288677
   PubMed Web of Science ®Google Scholar
• LiebowitzMLamRWLepolaUDattoCSweitzerDErikssonHEfficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trialDepress Anxiety2010271096497620734365
   PubMed Web of Science ®Google Scholar
• FindlingRLReedMDO’RiordanMADemeterCAStansbreyRJMcnamaraNKEffectiveness, safety, and pharmacokinetics of quetiapine in aggressive children with conduct disorderJ Am Acad Child Adolesc Psychiatry200645779280016832315
   PubMed Web of Science ®Google Scholar
• CabaleiroTLópez-RodríguezRRománMPharmacogenetics of quetiapine in healthy volunteers: association with pharmacokinetics, pharmacodynamics, and adverse effectsInt Clin Psychopharmacol2015302828825025989
   PubMed Web of Science ®Google Scholar
• PeuskensJThe management of schizophrenia: focus on extended-release quetiapine fumarateNeuropsychiatr Dis Treat2011754956422003295
   PubMed Web of Science ®Google Scholar
• MahatthanatrakulWRattanaKSriwiriyajanSWongnawaMRidtitidWBioequivalence study of a generic quetiapine in healthy male volunteersInt J Clin Pharmacol Ther200846948949618793579
   PubMed Web of Science ®Google Scholar
• JuniorEADuarteLFSuenagaEMde Carvalho CruzANakaieCRComparative bioavailability of two quetiapine formulations in healthy volunteers after a single dose administrationJ Bioequiv Availab20110308178181
   Google Scholar
• Estevez-CarrizoFEParrilloSErcoliMCEstevez-ParrilloFTSingle-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteersClin Ther201133673874521704238
   PubMed Web of Science ®Google Scholar
• BuiKEarleyWNybergSPharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implicationsCurr Med Res Opin201329781382523574265
   PubMed Web of Science ®Google Scholar
• BakkenGVRudbergIChristensenHMoldenERefsumHHermannMMetabolism of quetiapine by CYP3A4 and CYP3A5 in presence or absence of cytochrome B5Drug Metab Dispos200937225425819022943
   PubMed Web of Science ®Google Scholar
• DevaneCLNemeroffCBClinical pharmacokinetics of quetiapine: an atypical antipsychoticClin Pharmacokinet200140750952211510628
   PubMed Web of Science ®Google Scholar
• FlammiaDDValouchTVenutiSTissue distribution of quetiapine in 20 cases in VirginiaJ Anal Toxicol200630428729216803670
   PubMed Web of Science ®Google Scholar
• FDAClinical pharmacology and biopharmaceutics reviews for Seroquel XR2006 Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022047Orig1s000ClinPharmR.pdfAccessed June 23, 2018
   Google Scholar
• FDA [homepage on the Internet]Analytical procedures and methods validation for drugs and biologics-guidance for industry2015 Available from: https://www.fda.gov/downloads/drugs/guidancecompliance-regulatoryinformation/guidances/ucm386366.pdfAccessed June 23, 2018
   Google Scholar
• CFDA [homepage on the Internet]Technical guidelines for the study of human bioavailability and bioequivalence of chemical drug preparations2005 Available from: http://www.cde.org.cn/zdyz.do?method=largePage&id=2070Accessed June 23, 2018
   Google Scholar
• FDA [homepage on the Internet]Highlights of prescribing information2017 Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022047s039lbl.pdfAccessed June 24, 2018
   Google Scholar
• MandrioliRFanaliSFerrantiARaggiMAHPLC analysis of the novel antipsychotic drug quetiapine in human plasmaJ Pharm Biomed Anal200230496997712408887
   PubMed Web of Science ®Google Scholar
• BarrettBHolcapekMHuclováJValidated HPLC-MS/MS method for determination of quetiapine in human plasmaJ Pharm Biomed Anal200744249850517499470
   PubMed Web of Science ®Google Scholar
• ParkSParkCSLeeSJDevelopment and validation of a high-performance liquid chromatography-tandem mass spectrometric method for simultaneous determination of bupropion, quetiapine and escitalopram in human plasmaBiomed Chromatogr201529461261825262603
   PubMed Web of Science ®Google Scholar
• PanRNKuoBPPaoLHValidated LC-MS-MS method for the determination of quetiapine in human plasma: application to a pharmacokinetic studyJ Chromatogr Sci201250327728222337805
   PubMed Web of Science ®Google Scholar
• XiongXYangLDuanJDevelopment and validation of a sensitive and robust LC-MS/MS with electrospray ionization method for simultaneous quantitation of quetiapine and its active metabolite norquetiapine in human plasmaClin Chim Acta2013423697423623924
   PubMed Web of Science ®Google Scholar
• DavisPCBravoOGehrkeMAzumayaCTDevelopment and validation of an LC-MS/MS method for the determination of quetiapine and four related metabolites in human plasmaJ Pharm Biomed Anal20105151113111920022726
   PubMed Web of Science ®Google Scholar
• LiMZhangSShiAQiWLiuYDetermination of quetiapine in human plasma by LC-MS/MS and its application in a bioequivalence studyJ Chromatogr B Analyt Technol Biomed Life Sci201710601014
   PubMed Web of Science ®Google Scholar
• LiQSuYALiuYPharmacokinetics and tolerability of extended-release quetiapine fumarate in Han Chinese patients with schizophreniaClin Pharmacokinet201453545546524385309
   PubMed Web of Science ®Google Scholar